Related Experiment Video
Updated: Oct 25, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex
S Katie Z Ihnen1, Jamie K Capal2, Paul S Horn1
1Division of Neurology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Insights
Epilepsy in tuberous sclerosis complex (TSC) presents variably in young children. Two distinct epilepsy profiles, favorable and unfavorable, were identified based on seizure burden, impacting developmental outcomes.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Epilepsy is common in tuberous sclerosis complex (TSC), often starting early and proving difficult to treat.
- Significant individual variability exists in epilepsy presentation and severity within the TSC population.
Purpose of the Study:
- To define distinct epilepsy profiles in young children with TSC using prospective seizure data.
- To investigate the relationship between epilepsy profiles and developmental outcomes at 36 months.
Main Methods:
- Longitudinal follow-up of children aged 0-36 months with TSC.
- Daily seizure diaries maintained by caregivers for seizure type, onset, and count.
- Hierarchical clustering analysis of six seizure burden metrics to identify epilepsy profiles.
Main Results:
- Epilepsy affected 79% of participants, with 93% experiencing onset before 12 months.
- Two distinct epilepsy profiles (favorable and unfavorable) were identified based on seizure burden.
- Higher seizure burden was associated with poorer developmental outcomes at 36 months.
Conclusions:
- Epilepsy in TSC is phenotypically diverse, with at least two discernible subpopulations based on seizure burden.
- Early, targeted treatment strategies for TSC-related epilepsy should consider these distinct phenotypic profiles.
Background:
Epilepsy in tuberous sclerosis complex (TSC) typically presents with early onset, multiple seizure types, and intractability. However, variability is observed among individuals. Here, detailed individual data on seizure characteristics collected prospectively during early life were used to define epilepsy profiles in this population.
Methods:
Children aged zero to 36 months were followed longitudinally. Caregivers kept daily seizure diaries, including onset and daily counts for each seizure type. Patients with >70% seizure diary completion and >365 diary days were included. Developmental outcomes at 36 months were compared between subgroups.
Results:
Epilepsy was seen in 124 of 156 (79%) participants. Seizure onset occurred from zero to 29.5 months; 93% had onset before age 12 months. Focal seizures and epileptic spasms were most common. Number of seizures (for median 897 days) ranged from 1 to 9128. Hierarchical clustering based on six metrics of seizure burden (age of onset, total seizures, ratio of seizure days to nonseizure days, seizures per seizure day, and worst seven- and 30-day stretches) revealed two distinct groups with broadly favorable and unfavorable epilepsy profiles. Subpopulations within each group showed clinically meaningful differences in seizure burden. Groups with higher seizure burden had worse developmental outcomes at 36 months.
Conclusions:
Although epilepsy is highly prevalent in TSC, not all young children with TSC have the same epilepsy profile. At least two phenotypic subpopulations are discernible based on seizure burden. Early and aggressive treatments for epilepsy in TSC may be best leveraged by targeting specific subgroups based on phenotype severity.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...